Omacetaxine Mepesuccinate OverviewOmacetaxine mepesuccinate (INN, trade names Synribo or Myelostat ), formerly named as homoharringtonine or HHT, is a pharmaceutical drug substance that is indicated for treatment of chronic myeloid leukemia (CML). It is a natural product first discovered in Cephalotaxus harringtonii, now manufactured by hemi-synthesis. It was approved by the US FDA in October 2012 for the treatment of adult patients with CML with resistance and/or intolerance to two or more tyrosine kinase inhibitors (TKIs)....
Read more Omacetaxine Mepesuccinate Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Omacetaxine_mepesuccinate
Recent Omacetaxine Mepesuccinate Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Injection: 3.5mg/vial
- Powder: 3.5mg/vial
Other drugs which contain Omacetaxine Mepesuccinate or a similar ingredient: (1 result)
- SYNRIBO Omacetaxine Mepesuccinate